Precipio Inc (NASDAQ: PRPO) is having a strong start to the trading session in the market today, and for good reason. The company announced the launch of its global expansion strategy, leading to excitement among investors. Today, we’ll talk about:
- The expansion strategy launch;
- what we’re seeing from PRPO stock as a result; and
- what we’ll be wathing for ahead.
To read my detailed report on PRPO, click here!
PRPO Launches Global Expansion Strategy
As mentioned above, Precipio is having a strong start to the trading session this morning after announcing that it has launched its global expansion strategy. The news broke via press release early this morning.
In the release, the company announced the launch of global pathology services. It is believed that this launch will create a renewed and enhanced revenue stream through the expertise and network of world-class academic specialized oncology pathologists.
In the release, PRPO reminded investors that Ori Karev will be leading the charge. In fact, he has already started discussions with leading hospitals, healthcare providers and regional health insurance carriers to discuss the implementation of the company’s model and their respective countries.
In the release, the company said that it intends on targeting India, China, Malaysia, Europe, and gulf countries within the middle east initially. Much of these areas are accessible through Mr. Karev’s network.
In a statement, Ori Karev, Chief Strategy Officer at PRPO, had the following to offer:
Precipio has spent the last seven years building an extraordinary skill set and expertise, backed by solid data of results in the US. It is now time to take that expertise and translate it into revenue from multiple global partners who are eager to benefit from the same value proposition.
What We’re Seeing From The Stock
One of the first lessons that we learn when we start to work in the market is that the news leads to moves. When it comes to Precipio, the news proved to be overwhelmingly positive.
After all, the global launch, led by Ori Karev, will likely lead to a strong expansion in revenue, providing value to shareholders. So, it’s not surprising to see that excited investors are pushing the stock on a run for the top.
As is just about always the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (10:01), PRPO is trading at $0.50 per share after a gain of $0.02 per share or 4.15% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on PRPO. In particular, we’re interested in following the story surrounding the company’s continued work to bring its products and services around the world. Nonetheless, we’ll keep a close eye on the news and bring it to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!